Quratis, Inc. engages in the research and development of medicine and pharmaceutical products. Its businesses include vaccines, cell therapy platform, peptide nucleic acid, contract development, and manufacturing services. The company was founded on July 15, 2016 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company